Podcast
#47: Diagnostic Pathways to Women’s Health and Wellness
Duration: 15 Minutes
May 22, 2025
In this episode, you'll hear a conversation with three women's health experts about how early diagnostic testing is transforming care for heart disease, STIs, and preeclampsia. Discover how proactive screening empowers women, supports personalized care, and helps shift healthcare from reaction to prevention.
Disclaimers:
This educational podcast activity is brought to you by QuidelOrtho Corporation., and is not certified for continuing medical education. QuidelOrtho Corporation sponsors the program, and the speaker must present information following applicable FDA requirements.
High-sensitivity troponin testing is not available in all regions. Please reach out to your QuidelOrtho representative for more information, or visit our website at quidelortho.com.
About our Speaker:
About our Speaker:
Dr. Rea Castro
Director, Medical Affairs
QuidelOrtho
Rea is a seasoned medical professional with extensive experience in pharmaceutical clinical development, biotechnology and diagnostic product development across multiple therapeutic areas, including immunology, oncology and women's health. She is currently a cross-functional leader in medical affairs and is committed to advancing healthcare outcomes through innovative research, quality healthcare delivery and rigorous safety standards.
Rea is a seasoned medical professional with extensive experience in pharmaceutical clinical development, biotechnology and diagnostic product development across multiple therapeutic areas, including immunology, oncology and women's health. She is currently a cross-functional leader in medical affairs and is committed to advancing healthcare outcomes through innovative research, quality healthcare delivery and rigorous safety standards.
About our Speaker:
About our Speaker:
Dr. Lindy Crimmins
Global Medical Affairs Manager
QuidelOrtho
Lindy's clinical experience spans from emergency medicine to critical and primary care. Currently, she is responsible for providing medical support for the QuidelOrtho acute care menu throughout the product lifecycle. Lindy is passionate about education, testing guideline updates and assay utilization to drive improved patient-centered outcomes.
Lindy's clinical experience spans from emergency medicine to critical and primary care. Currently, she is responsible for providing medical support for the QuidelOrtho acute care menu throughout the product lifecycle. Lindy is passionate about education, testing guideline updates and assay utilization to drive improved patient-centered outcomes.
About our Speaker:
About our Speaker:
Vonda McAllister
Director of Global Product Management
QuidelOrtho
Vonda's diagnostic experience spans from R&D and program management to marketing. Now a member of the Point of Care business unit, she previously managed the Triage™ portfolio of assays and the clinical labs team for North America. Vonda is currently focused on supporting the global regions with our PlGF tests, that is, placental growth factor, and toxicology assays, as well as expanding the Triage toxicology and women's health testing portfolio. She also serves as global leadership co-chair for the QuidelOrtho Women's Leadership Network.
Vonda's diagnostic experience spans from R&D and program management to marketing. Now a member of the Point of Care business unit, she previously managed the Triage™ portfolio of assays and the clinical labs team for North America. Vonda is currently focused on supporting the global regions with our PlGF tests, that is, placental growth factor, and toxicology assays, as well as expanding the Triage toxicology and women's health testing portfolio. She also serves as global leadership co-chair for the QuidelOrtho Women's Leadership Network.
In this episode, you'll learn:
- How early diagnostics are transforming women’s health from reactive care to proactive prevention, with a focus on cardiovascular disease, STIs, and pregnancy-related conditions like preeclampsia.
- The importance of personalized, routine testing and self-advocacy in identifying risks before symptoms appear, especially in conditions where women often present differently or are underdiagnosed.
- Innovations in rapid and point-of-care diagnostics that improve access, reduce stigma, and enhance outcomes for underserved populations.
- The critical role of interdisciplinary collaboration—from diagnostic developers to healthcare providers—in ensuring test results translate into actionable, equitable care plans for women.
